AQUINOX PHARMACEUTICALS INC's ticker is AQXP and the CUSIP is 03842B101. A total of 38 filers reported holding AQUINOX PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $349,000 | -12.3% | 147,800 | 0.0% | 0.00% | -20.0% |
| Q1 2019 | $398,000 | +50.8% | 147,800 | +64.2% | 0.01% | +66.7% |
| Q3 2018 | $264,000 | +98.5% | 90,000 | +80.0% | 0.00% | +200.0% |
| Q2 2018 | $133,000 | -81.1% | 50,000 | 0.0% | 0.00% | -87.5% |
| Q1 2018 | $704,000 | +19.7% | 50,000 | 0.0% | 0.01% | +33.3% |
| Q4 2017 | $588,000 | -17.2% | 50,000 | 0.0% | 0.01% | -25.0% |
| Q3 2017 | $710,000 | +0.9% | 50,000 | 0.0% | 0.01% | 0.0% |
| Q2 2017 | $704,000 | -15.7% | 50,000 | 0.0% | 0.01% | -20.0% |
| Q1 2017 | $835,000 | +1.1% | 50,000 | 0.0% | 0.01% | -9.1% |
| Q4 2016 | $826,000 | -0.2% | 50,000 | -19.4% | 0.01% | -8.3% |
| Q3 2016 | $828,000 | +102.0% | 62,000 | 0.0% | 0.01% | +100.0% |
| Q2 2016 | $410,000 | +286.8% | 62,000 | +416.7% | 0.01% | +200.0% |
| Q1 2016 | $106,000 | -43.3% | 12,000 | -20.0% | 0.00% | -33.3% |
| Q4 2015 | $187,000 | -11.4% | 15,000 | 0.0% | 0.00% | -25.0% |
| Q3 2015 | $211,000 | +102.9% | 15,000 | 0.0% | 0.00% | +100.0% |
| Q2 2015 | $104,000 | – | 15,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|